Low SIRT3 expression and subsequent hyperacetylation and inactivation of SOD2 are thought to play a major role in the O2•−-driven activation of HIF-1α [166,167], leading to increased glycolysis in tumor cells [168]. The gene discussed is SIRT3; the disease is neoplasm.